Cyfuse Biomedical K.K. (4892.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−4.0x

Market Cap

JPY 5.17B

MomentumView details →

1D Return

+4.45%

YTD Return

+3.56%

RSI (14)

69.8

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−4.0x

Market Cap

JPY 5.17B

RSI (14)

69.8

MomentumView details →

1D Return

+4.45%

YTD Return

+3.56%

ProfitabilityView details →

Gross Margin

49.52%

Net Margin

−331.74%

EBITDA Margin

−344.57%

ROE (TTM)

−27.68%

ROA (TTM)

−17.89%

Asset Turnover

0.05x

GrowthView details →

Revenue YoY

+325.93%

EPS YoY

+16.90%

FCF YoY

—

Revenue CAGR 3Y

−14.96%

EPS CAGR 3Y

+19.90%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.41x

Current Ratio

4.54x

Quick Ratio

4.49x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

234.00M

Net Income (TTM)

−825.00M

Op. CF (TTM)

—

Next earningsNov 12, 2026 →

Latest newsMore news →

No recent news for 4892.T.

Similar companies

Chordia Therapeutics Inc.190A.T TMS Co.,Ltd.4891.T D.Western Therapeutics Institute, Inc.4576.T Chiome Bioscience Inc.4583.T NIPPON CHEMIPHAR CO.,LTD.4539.T BrightPath Biotherapeutics Co.,Ltd.4594.T Find similar companies →

Latest newsMore news →

No recent news for 4892.T.